Fish Skin Technology

Kerecis Has Obtained 510(K) Approval From FDA for The Treatment of Chronic Wounds
Nov 12, 2013
Iceland-based Kerecis has obtained 510(k) approval from the US Food and Drug Administration (FDA) to market its fish-skin, Omega3, tissue-regeneration technology for the treatment of chronic wounds in the US. The company will market the ...

Tags: Kerecis, PDA, Fish-Skin Technology, chronic wounds